Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) have announced that the National Institute for Health and Care Excellence (NICE), a non-departmental public body of the Department of Health in the United Kingdom, issued a second draft guidance on the use of PIXUVRI(®) (pixantrone) as a...